HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel flavonoid, 6-C-beta-d-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon mitigates ovariectomy-induced osteoporosis in rats.

AbstractOBJECTIVE:
The aim of this study was to determine the skeletal effect of 6-C-beta-d-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanone (GTDF)/Ulmoside A, a new compound isolated from the extract of Ulmus wallichiana in a rat model of postmenopausal bone loss.
METHODS:
GTDF (1.0 and 5.0 mg kg d) was given orally to ovariectomized (OVx) rats (180-200 g) for 12 weeks. Sham operated + vehicle, ovariectomy + 17beta-estradiol (2.5 microg kg d), and ovariectomy + vehicle groups served as various controls. Bone mineral density (BMD), trabecular microarchitecture, bone biomechanical strength, levels of bone turnover/resorption markers, uterotropic effect, and plasma pharmacokinetics were studied. One-way analysis of variance was used to test significance of effects.
RESULTS:
OVx rats treated with both doses of GTDF exhibited significantly higher BMD in the trabecular (distal femur, proximal tibia, and vertebrae) and cortical (femur shaft) regions compared with the ovariectomy + vehicle group. Micro-CT demonstrated that OVx rats treated with 5.0 mg kg day of GTDF had better bone microarchitectural parameters compared with the ovariectomy + vehicle group. Serum osteocalcin and urinary C-terminal teleopeptide of Type I collagen levels in OVx rats treated with GTDF (at both doses) were significantly lower than those in the ovariectomy + vehicle group. At neither of the two doses did GTDF exhibit uterine estrogenicity. A pharmacokinetic study revealed that GTDF achieved maximum plasma concentration (40.67 ng mL) at approximately 1 hour, indicating its slow absorption. Its absolute bioavailability was found to be 1.04% with a plasma elimination half-life of approximately 5 hours.
CONCLUSIONS:
GTDF, a novel compound isolated from U wallichiana extract, improves bone biomechanical quality through positive modifications of BMD and trabecular microarchitecture without a hyperplastic effect on the uterus.
AuthorsKunal Sharan, Gaurav Swarnkar, Jawed A Siddiqui, Avinash Kumar, Preeti Rawat, Manmeet Kumar, Geet K Nagar, Lakshmi Manickavasagam, Sheelendra P Singh, Geetanjali Mishra, Wahajuddin, Girish K Jain, Rakesh Maurya, Naibedya Chattopadhyay
JournalMenopause (New York, N.Y.) (Menopause) 2010 May-Jun Vol. 17 Issue 3 Pg. 577-86 ISSN: 1530-0374 [Electronic] United States
PMID20393370 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Flavonoids
  • Glycosides
  • Plant Extracts
  • ulmoside A
  • Osteocalcin
Topics
  • Animals
  • Bone Density (drug effects)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Flavonoids (administration & dosage, pharmacology)
  • Glycosides (administration & dosage, pharmacology)
  • Half-Life
  • Osteoblasts (drug effects)
  • Osteocalcin (blood)
  • Osteogenesis (drug effects)
  • Osteoporosis (drug therapy, prevention & control)
  • Ovariectomy
  • Plant Extracts (administration & dosage)
  • Rats
  • Rats, Sprague-Dawley
  • Ulmus

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: